Find your path to David
130 people in our graph share verified history with David — schools, employers, funds. One of them is your warm intro.
Crystal HuangunlockedDavid: together at New Enterprise Associates (NEA)
×11David: together at New Enterprise Associates (NEA)
About
David Mott led New Enterprise Associates' healthcare investing as a general partner after serving as chief executive of biotech company MedImmune, which AstraZeneca acquired for $15.6 billion.
Deals · 1
TesaroBoard seat
via New Enterprise Associates (NEA) · filed Apr 2016 · $50M raise
Attribution from SEC filings, press coverage, and firm rosters.
Colleagues at New Enterprise Associates (NEA)
Aaron Jacobson
Partner at New Enterprise Associates (NEA)
Alex Sharata
Partner at New Enterprise Associates (NEA)
Alexa Grabelle
Associate at New Enterprise Associates (NEA)
Ali Behbahani
Partner, Co-Head of Healthcare at New Enterprise Associates (NEA)
Andrew Schoen
Partner at New Enterprise Associates (NEA)
Ann Bordetsky
Partner at New Enterprise Associates (NEA)
Arjun Jain
Partner at New Enterprise Associates (NEA)
Aya Somai
Associate at New Enterprise Associates (NEA)
Frequently asked questions
- Who is David Mott?
- David Mott led New Enterprise Associates' healthcare investing as a general partner after serving as chief executive of biotech company MedImmune, which AstraZeneca acquired for $15.6 billion.
- Where does David Mott work?
- David Mott is General Partner at New Enterprise Associates (NEA).
- What boards does David Mott sit on?
- David Mott holds tracked board seats at Tesaro.